Marex Group PLC Ab Cellera Biologics Inc. Transaction History
Marex Group PLC
- $11.1 Billion
- Q2 2025
A detailed history of Marex Group PLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Marex Group PLC holds 20,000 shares of ABCL stock, worth $117,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$117,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABCL
# of Institutions
151Shares Held
115MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$161 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$78.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$60.7 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$49.6 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$26.6 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.67B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...